Jennison Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Jennison Associates’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,725,800	Closed	-$107M	–	730
2014 Q4	$107M	Sell	1,725,800 -21,204	-1%	-$1.05M	0.1%	199
2014 Q3	$67.8M	Buy	1,747,004 +2,182	+0.1%	+$77.3K	0.06%	274
2014 Q2	$60.1M	Sell	1,744,822 -170,722	-9%	-$5.38M	0.06%	300
2014 Q1	$82.8M	Buy	1,915,544 +8,161	+0.4%	+$396K	0.08%	229
2013 Q4	$76M	Sell	1,907,383 -5,710	-0.3%	-$203K	0.07%	239
2013 Q3	$71.8M	Sell	1,913,093 -332,408	-15%	-$9.93M	0.08%	238
2013 Q2	$60.3M	Buy	+2,245,501	New	+$47.7M	0.07%	259

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jennison Associates's IONS Position: Q1 2015 in Review

Jennison Associates sold out of Ionis Pharmaceuticals (IONS) in Q1 2015, closing a stake of 1,725,800 shares — an estimated $107M sold.

Jennison Associates first reported a position in IONS in Q2 2013 and held it in 7 quarters. The position peaked at $107M in Q4 2014. 339 funds tracked by Wall St. Rank hold IONS as of Q1 2015.

Jennison Associates reported no remaining Ionis Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Jennison Associates sold 1,725,800 Ionis Pharmaceuticals shares in Q1 2015, an estimated $107M.
Jennison Associates first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Jennison Associates's Ionis Pharmaceuticals position peaked at $107M in Q4 2014.
339 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2015.

Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.